Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Bitdeer Technologies Group (BTDR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud... (PR Newswire) +++ BITDEER Aktie -3,83%

BRUKER Aktie

 >BRUKER Aktienkurs 
45.54 EUR    +1.1%    (Tradegate)
Ask: 47.05 EUR / 127 Stück
Bid: 46.58 EUR / 128 Stück
Tagesumsatz: 1565 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
BRUKER Aktie über LYNX handeln
>BRUKER Performance
1 Woche: +13,1%
1 Monat: +16,3%
3 Monate: +46,3%
6 Monate: +26,6%
1 Jahr: -22,9%
laufendes Jahr: +11,6%
>BRUKER Aktie
Name:  BRUKER CORP. DL -,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US1167941087 / 813534
Symbol/ Ticker:  BKD (Frankfurt) / BRKR (NASDAQ)
Kürzel:  FRA:BKD, ETR:BKD, BKD:GR, NASDAQ:BRKR
Index:  -
Webseite:  https://ir.bruker.com/
Profil:  Bruker Corporation is a leading developer and manu..
>Volltext..
Marktkapitalisierung:  6660.75 Mio. EUR
Unternehmenswert:  8177.91 Mio. EUR
Umsatz:  2941.53 Mio. EUR
EBITDA:  392.53 Mio. EUR
Nettogewinn:  -17.88 Mio. EUR
Gewinn je Aktie:  -0.13 EUR
Schulden:  1718.01 Mio. EUR
Liquide Mittel:  250.71 Mio. EUR
Operativer Cashflow:  80.66 Mio. EUR
Bargeldquote:  0.23
Umsatzwachstum:  0.67%
Gewinnwachstum:  -106.5%
Dividende je Aktie:  0.17 EUR
Dividendenrendite:  0.39%
Dividendenschätzung:  4.11%
Div. Historie:  08.12.25 - 0.043€
23.09.25 - 0.0429€
>weitere anzeigen...
Insiderhandel:  1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 1.680.647 USD.
Suchwörter:  BRUKER
Letzte Datenerhebung:  09.01.26
>BRUKER Kennzahlen
Aktien/ Unternehmen:
Aktien: 151.94 Mio. St.
Frei handelbar: 67.92%
Rückkaufquote: -8.56%
Mitarbeiter: 11396
Umsatz/Mitarb.: 0.25 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: -4.3%
Bewertung:
KGV: -
KGV lG: 28.5
KUV: 2.21
KBV: 3.33
PEG-Ratio: -
EV/EBITDA: 20.83
Rentabilität:
Bruttomarge: 48%
Gewinnmarge: -0.61%
Operative Marge: 7.09%
Managementeffizenz:
Gesamtkaprendite: -0.33%
Eigenkaprendite: -0.99%
>BRUKER Peer Group

Es sind 595 Aktien bekannt.
 
09.01.26 - 16:18
Bruker Secures $500 Million In Long-Term Supply Orders (Benzinga)
 
Bruker BEST division announced $500M supply deals with global radiology companies for advanced superconductors used in MRI magnets. read more...
09.01.26 - 13:30
Bruker secures $500M in multi-year MRI superconductor orders (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.01.26 - 13:03
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied Markets (Business Wire)
 
TOFWERK is a profitable innovator in compact, ultra-fast time-of-flight (TOF) mass spectrometry for real-time air and semiconductor cleanroom monitoring, food, flavors & fragrances markets, and FIB-TOF accessories for electron microscopes The ultra-sensitive Vocus™ TOF-MS is customizable for real-time air and cleanroom monitoring applications Microwave-induced plasma (MIP)-TOF systems with atto-to-femtogram detection limits for real-time quantification of trace elements and metals Proprietary flow tube-based VUV CI sources for positive and negative trace organics, inorganics and PFAS contaminants Focused Ion Beam (FIB)-TOF accessories for scanning electron microscopes THUN, Switzerland--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of an additional 60% ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100%. T...
07.01.26 - 00:01
Insiderhandel: EXEC VP&PRES BRUKER NANO INC. verkauft Aktien von Bruker im Wert von 1680647 USD (Insiderkauf)
 
Munch, Mark - Vorstand - Tag der Transaktion: 2026-01-05...
26.12.25 - 18:12
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide (Fool)
 
The sale isn't about panic selling, but it is about what happens when growth stumbles, margins compress, and opportunity cost suddenly matters a lot more....
26.12.25 - 15:15
Should You Continue to Hold BRKR Stock in Your Portfolio? (Zacks)
 
Bruker's innovation pipeline and acquisitions support long-term growth, but macro pressures and funding risks cloud the stock's near-term outlook....
18.12.25 - 17:48
AbCellera-Aktie legt nach Einigung im Patentstreit mit Bruker zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
18.12.25 - 16:00
AbCellera settles patent litigation with Bruker over microfluidic device tech (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.12.25 - 14:33
Bruker raised to Outperform at Wolfe on 2026 outlook (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
10.12.25 - 13:21
Bruker wins $25 million in magnetic resonance system orders from leading European institutions (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
08.12.25 - 14:03
Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026 (Business Wire)
 
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has added Jack J. Phillips to serve on its board of directors, effective as of January 1st, 2026. Mr. Phillips is a senior healthcare industry executive with over 30 years of leadership experience in the diagnostics industry. Frank H. Laukien, chairman, president and CEO of Bruker Corporation, stated: “Bruker is delighted to add Jack to our board of directors. His broad and deep diagnostics experience, strategic acumen and market development experience will be very valuable to Bruker and our board. I admire Jack's proven ability to translate scientific innovations into clinical impact for patient benefit and to accelerate profitable business growth in diagnostics. Jack's addition to our board is timely, as we broaden our infectious disease diagnostics portfolio, and increasingly leverage our unique disease biology research tools for opportunities in specialty diagnostics.” Ja...
03.12.25 - 19:00
Bruker (BRKR) Up 17.1% Since Last Earnings Report: Can It Continue? (Zacks)
 
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
03.12.25 - 01:01
Insiderhandel: Aufsichtsrat verkauft Aktien von Bruker im Wert von 243230 USD (Insiderkauf)
 
Packer, Richard A. - Aufsichtsrat - Tag der Transaktion: 2025-12-01...
19.11.25 - 00:12
Bruker auf Wolfe Research Konferenz: Strategische Einblicke und Margenziele bis 2026/n (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
11.11.25 - 02:01
Insiderhandel: Aufsichtsrat verkauft Aktien von Bruker im Wert von 243087 USD (Insiderkauf)
 
Ornell, John A. - Aufsichtsrat - Tag der Transaktion: 2025-11-06...
04.11.25 - 22:48
Bruker declares $0.05 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.11.25 - 22:36
Why Bruker Stock Slumped Monday (Fool)
 
The market was mildly displeased with the company's reduced 2025 guidance....
04.11.25 - 22:03
Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
 
BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors (“Board”) has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company's common stock, par value $0.01 per share (the “Common Stock Dividend”). The Common Stock Dividend will be paid on January 2, 2026 to stockholders of record as of December 8, 2025. The Board also approved payment of a quarterly cash dividend in the amount of $3.6745 per share on the Company's 6.375% Mandatory Convertible Preferred Stock, Series A, par value $0.01 per share (the “Mandatory Convertible Preferred Stock Dividend”). The Mandatory Convertible Preferred Stock Dividend will be paid on December 1, 2025 to stockholders of record as of November 15, 2025. About Bruker Corporation – Leader of the Post-Genomic Era Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the qu...
04.11.25 - 22:00
Why This Investment Advisor Sold Off Its $3.6 Million Bruker Stake (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
04.11.25 - 01:00
Bruker Shares Rise After Q3 Earnings Beat, but Guidance Is Cautious (24/7 Wall St.)
 
Bruker Corporation (NASDAQ: BRKR) delivered a sharp earnings beat this morning, lifting shares nearly 7% despite underlying headwinds that reveal a company in transition. Non-GAAP EPS of $0.45 crushed the $0.34 consensus estimate by 32%, but the real story sits beneath the headline: organic revenue is contracting, margins are compressing and restructuring charges are masking ... Bruker Shares Rise After Q3 Earnings Beat, but Guidance Is Cautious The post Bruker Shares Rise After Q3 Earnings Beat, but Guidance Is Cautious appeared first on 24/7 Wall St.....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Familie und Beruf sind super miteinander zu vereinbaren, wenn der Schwerpunkt auf der Familie liegt. - Jürgen Klopp
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!